Pulmonary Hypertension Association home
Pulmonary Hypertension Association
 contact us | join PHA | site map/search

PHA News Archive - January 14, 2005

vol 6, Number 1

PHA News January 14, 2005
PHA News is an e-mail newsletter from the Pulmonary Hypertension Association covering PH related topics.

PHA News editor - Sally Maddox skmaddox@bellsouth.net
reaching over 4900 subscribers

www.phassociation.org

Topics For This Issue
Daring test targets fatal lung disease
Viagra helps boy with lung disease
Professor's grant supports sickle cell-related research
Hunting A Cure: Researchers experiment with therapies to treat scleroderma, a disease that hardens body tissue

Daring test targets fatal lung disease
Eighteen people with less than a year to live are to take part in an unprecedented medical experiment that is as dazzling as it is daring.

A group of Toronto doctors has received Health Canada's permission to test in humans a combination of medicine's hottest ingredients: stem cells and gene therapy.

The molecular concoction is a potential treatment for an incurable lung condition called pulmonary arterial hypertension (PAH) that can leave people breathless just combing their hair. It affects more than 7,000 Canadians as the blood vessels of their lungs shrivel.

Read more...
(
http://www.theglobeandmail.com/servlet/ArticleNews/
TPStory/LAC/20050112/HTHERA12/TPHealth/
)

(requires free registration)

Viagra helps boy with lung disease

A New Brunswick boy is getting help for his lung condition from an unexpected source – Viagra.

Braden Gendron, 6, has pulmonary hypertension, or PH, a rare and usually fatal condition affecting the lungs and heart. The only cure is a lung transplant.

Read Article
(http://www.cbc.ca/story/science/national/2005/01/10/viagra-lung-disease050110.html)

Professor's grant supports sickle cell-related research

Daniel B. Kim-Shapiro, associate professor of physics at Wake Forest University, has been awarded an Independent Scientist Career Development Award (K02) from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) for his project "Nitrite and Nitric Oxide in Sickle Cell Blood."

Read Article
(http://www.wfu.edu/wfunews/2005/010505k.html)

Hunting A Cure: Researchers experiment with therapies to treat scleroderma, a disease that hardens body tissue

Cheryl Argiros of Coventry, Conn., already has participated in four clinical trials of experimental treatments for scleroderma, a disease that turns skin to the consistency of mahogany. It has scarred her lungs and turned her hands into claws.

Researchers say that the prospects of developing new therapies to treat the connective-tissue disease have never been better. More than 10 new treatments - including vaccines, stem-cell transplants and specialized antibodies currently - are being tested in patients.

Read more
(http://www.journalnow.com/servlet/
Satellite?pagename=WSJ%2FMGArticle%2FWSJ_
BasicArticle&c=MGArticle&cid=1031779998194&
path=!living&s=1037645509005
)


Better Business Bureau Accredited Charity bbb.org/charity Charity Navigator 4 Star Charity Rating best in america seal


The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

Questions about the site? email web@PHAssociation.org

Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910

Copyright © 2008 Pulmonary Hypertension Association
Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher
Macintosh: Internet Explorer 5.2 or higher
free download from Microsoft.com

  Macromedia Flash Player
free download from Macromedia.com
  Adobe Acrobat Reader 6.0 or higher
free download from Adobe.com
Patients Medical Caregivers Media What is PH